Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Medical Genetics|July 1, 2016
Mutations in MYT1, encoding the myelin transcription factor 1, are a rare cause of OAVSEstelle Lopez, Marie Berenguer, Angèle Tingaud-Sequeira, et al.
Environment International|December 10, 2013
Effects of BDE-209 contaminated sediments on zebrafish development and potential implications to human healthNatàlia Garcia-Reyero, B Lynn Escalon, Eva Prats, et al.
Scientific Reports|October 23, 2015
Zebrafish Models for Human Acute Organophosphorus PoisoningMelissa Faria, Natàlia Garcia-Reyero, Francesc Padrós, et al.
Neurobiology of Disease|November 29, 2016
Functional validation of ABHD12 mutations in the neurodegenerative disease PHARCAngèle Tingaud-Sequeira, Demetrio Raldúa, Julie Lavie, et al.
Biochemical Pharmacology|April 8, 2022
Obesity III: Obesogen assays: Limitations, strengths, and new directionsChristopher D Kassotis, Frederick S Vom Saal, Patrick J Babin, et al.
Human Mutation|October 17, 2017
CYP2U1 activity is altered by missense mutations in hereditary spastic paraplegia 56Christelle M Durand, Laura Dhers, Christelle Tesson, et al.
FEBS Letters|August 12, 2022
Combinatorial pathway disruption is a powerful approach to delineate metabolic impacts of endocrine disruptorsKévin Bernal, Charbel Touma, Chedi Erradhouani, et al.
American Journal of Medical Genetics. Part A|May 1, 2014
New candidate loci identified by array-CGH in a cohort of 100 children presenting with syndromic obesityMarie-Laure Vuillaume, Sophie Naudion, Guillaume Banneau, et al.
Brain : a Journal of Neurology|December 12, 2017
Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5Cecilia Marelli, Foudil Lamari, Dominique Rainteau, et al.
Frontiers in Toxicology|May 14, 2024
New approach methods to assess developmental and adult neurotoxicity for regulatory use: a PARC work package 5 projectTamara Tal, Oddvar Myhre, Ellen Fritsche, et al.
Pageof 5